Vor Biopharma Inc.
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
VOR | NDAQ
Overview
Corporate Details
- ISIN(s):
- US9290331084
- LEI:
- Country:
- United States of America
- Address:
- 500 BOYLSTON STREET, 2116 BOSTON
- Website:
- https://www.vorbio.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Vor Biopharma Inc. is a clinical-stage biotechnology company focused on developing a new generation of medicines for autoimmune diseases. The company is advancing breakthrough science to create treatments that go beyond symptom control by targeting the fundamental drivers of autoimmunity. Its lead program features telitacicept, a therapy designed to silence the signals that allow harmful immune cells to survive, with the goal of delivering safer, longer-lasting treatments. Vor Bio aims to restore balance to the immune system and meaningfully improve the lives of patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Vor Biopharma Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Vor Biopharma Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Vor Biopharma Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
